TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 187 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $280,000 | -55.8% | 28,820 | -51.1% | 0.10% | 0.0% |
Q1 2021 | $633,000 | -35.4% | 58,938 | -11.5% | 0.10% | -29.5% |
Q4 2020 | $980,000 | +19.2% | 66,616 | +15.1% | 0.14% | -2.8% |
Q3 2020 | $822,000 | +100.0% | 57,860 | +13.9% | 0.14% | +76.5% |
Q2 2020 | $411,000 | +463.0% | 50,783 | +180.4% | 0.08% | +35.0% |
Q1 2020 | $73,000 | – | 18,109 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
Artal Group S.A. | 150,000 | $870,000 | 0.02% |
Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |